0
Bio-Techne Banner Image

Bio-Techne

  • Ticker TECH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Bio-Techne Logo Image
  • 1001-5000 Employees
  • Based in Minneapolis, Minnesota
Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits used by researchersMore to quantify the level of a specific protein in biological fluids, such as serum, plasma, or urine; and clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices.
REPORT RATINGS
4.7 / 5.0 (221)

Bio-Techne reports have an aggregate usefulness score of 4.7 based on 221 reviews.

Bio-Techne

Most Recent Annual Report

Bio-Techne
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Bio-Techne Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!